Abstract
CancerVolume 77, Issue 5 p. 1002-1002 CorrespondenceFree Access Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer: A Southwest Oncology Group study Giuseppe Colucci M.D., Corresponding Author Giuseppe Colucci M.D. Department of Medicine, Oncology Institute, Via Amendola 209, Bari, ItalyDepartment of Medicine, Oncology Institute, Via Amendola 209, Bari, Italy===Search for more papers by this author Giuseppe Colucci M.D., Corresponding Author Giuseppe Colucci M.D. Department of Medicine, Oncology Institute, Via Amendola 209, Bari, ItalyDepartment of Medicine, Oncology Institute, Via Amendola 209, Bari, Italy===Search for more papers by this author First published: 1 March 1996 https://doi.org/10.1002/(SICI)1097-0142(19960301)77:5<1002::AID-CNCR29>3.0.CO;2-6AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Berenberg JL, Tangen C, Macdonald JS, Hutchins LF, Natale RB, Oishi N, et al. Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study. Cancer 1995; 76: 715– 8. 2 Colucci G, Maiello E, Lacatena M, Giuliani F, Pezzella G, Giotta F, et al. Folinic acid (FA) + FU alone or with 4-epidoxorubicin in advanced gastric carcinoma. Ann Oncol 1990; 1(suppl): 45 (abstr). 3 Colucci G, Giotta F, Maiello E, Cifarelli RA, Leo S, Giuliani F, et al. Efficacy of the Association of Folinic Acid and 5-Fluorouracil Plus 4-Epidoxorubicin in the Treatment of Advanced Gastric Carcinoma. Am J Clin Oncol 1995; 18: 519– 24. Volume77, Issue51 March 1996Pages 1002-1002 ReferencesRelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
